Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage

Neuroscience Letters

Volumn 492, Issue 1, 2011, Pages 23-28

  Silverstein, Julie M ^a   Musikantow, Daniel ^b   Puente, Erwin C ^a   Daphna Iken, Dorit ^a   Bree, Adam J ^a   Fisher, Simon J ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cortex; Erythropoietin; Hippocampus; Insulin; Memantine

Indexed keywords

GLUCOSE; MEMANTINE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN SLICE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; CELL COUNT; CEREBRAL CORTEX; ERYTHROPOIETIN; HIPPOCAMPUS; HYPOGLYCEMIA; INSULIN; MALE; MEMANTINE; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79952009475     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.01.045     Document Type: Article

References (55)

1. Alkire M.T., Pomfrett C.J., Haier R.J., Gianzero M.V., Chan C.M., Jacobsen B.P., Fallon J.H. Functional brain imaging during anesthesia in humans: effects of halothane on global and regional cerebral glucose metabolism. Anesthesiology 1999, 90:701-709.
2. Auer R.N. Hypoglycemic brain damage. Metab. Brain Dis. 2004, 19:169-175.
3. Auer R.N., Siesjo B.K. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann. Neurol. 1988, 24:699-707.
4. Austin E.J., Deary I.J. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the diabetes control and complications trial data. Diabetes Care 1999, 22:1273-1277.
5. Bernal F., Saura J., Ojuel J., Mahy N. Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity. Exp. Neurol. 2000, 161:686-695.
6. Bjorgaas M., Gimse R., Vik T., Sand T. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr. 1997, 86:148-153.
7. Block F., Schwarz M. Memantine reduces functional and morphological consequences induced by global ischemia in rats. Neurosci. Lett. 1996, 208:41-44.
8. Bree A.J., Puente E.T., Daphna-Iken D., Fisher S. Diabetes increases brain damage caused by severe hypoglycemia. Am. J. Physiol. Endocrinol. Metab 2009, 297:E194-E201.
9. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 2000, 97:10526-10531.
10. Butcher S.P., Sandberg M., Hagberg H., Hamberger A. Cellular origins of endogenous amino acids released into the extracellular fluid of the rat striatum during severe insulin-induced hypoglycemia. J. Neurochem. 1987, 48:722-728.
11. Canal C.E., McNay E.C., Gold P.E. Increases in extracellular fluid glucose levels in the rat hippocampus following an anesthetic dose of pentobarbital or ketamine-xylazine: an in vivo microdialysis study. Physiol Behav. 2005, 84:245-250.
12. Cardoso S, Santos M.S., Seica R., Moreira P.I. Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia. Biochim. Biophys. Acta 2010, 1802:942-951.
13. Chen H.S., Lipton S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 2006, 97:1611-1626.
14. Cryer P.E. The barrier of hypoglycemia in diabetes. Diabetes 2008, 57:3169-3176.
15. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial, Ann. Intern. Med., 124 (1996) 379-388.
16. Gorgulu A., Kins T., Cobanoglu S., Unal F., Izgi N.I., Yanik B., Kucuk M. Reduction of edema and infarction by Memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat. Acta Neurochir. (Wien.) 2000, 142:1287-1292.
17. Hershey T., Lillie R., Sadler M., White N.H. Severe hypoglycemia and long-term spatial memory in children with type 1 diabetes mellitus: a retrospective study. J. Int. Neuropsychol. Soc. 2003, 9:740-750.
18. Jacobson A.M., Musen G., Ryan C.M., Silvers N., Cleary P., Waberski B., Burwood A., Weinger K., Bayless M., Dahms W., Harth J. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 2007, 356:1842-1852.
19. Jeong Y.B., Kim J.S., Jeong S.M., Park J.W., Choi I.C. Comparison of the effects of sevoflurane and propofol anaesthesia on regional cerebral glucose metabolism in humans using positron emission tomography. J. Int. Med. Res. 2006, 34:374-384.
20. Jiang X., Mu D., Manabat C., Koshy A.A., Christen S., Tauber M.G., Vexler Z.S., Ferriero D.M. Differential vulnerability of immature murine neurons to oxygen-glucose deprivation. Exp. Neurol. 2004, 190:224-232.
21. Johnson S.A., Young C., Olney J.W. Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J. Neurosurg. Anesthesiol. 2008, 20:21-28.
22. Kaufman F.R., Epport K., Engilman R., Halvorson M. Neurocognitive functioning in children diagnosed with diabetes before age 10 years. J. Diabetes Complications 1999, 13:31-38.
23. Kramer L., Fasching P., Madl C., Schneider B., Damjancic P., Waldhausl W., Irsigler K., Grimm G. Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes 1998, 47:1909-1914.
24. Liao Z.B., Zhi X.G., Shi Q.H., He Z.H. Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur. J. Neurol. 2008, 15:140-149.
25. Lu D., Mahmood A., Qu C., Goussev A., Schallert T., Chopp M. Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J. Neurotrauma 2005, 22:1011-1017.
26. Musen G., Lyoo I.K., Sparks C.R., Weinger K., Hwang J., Ryan C.M., Jimerson D.C., Hennen J., Renshaw P.F., Jacobson A.M. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006, 55:326-333.
27. Nakao Y., Itoh Y., Kuang T.Y., Cook M., Jehle J., Sokoloff L. Effects of anesthesia on functional activation of cerebral blood flow and metabolism. Proc. Natl. Acad. Sci. USA 2001, 98:7593-7598.
28. Nellgard B., Wieloch T. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp. Brain Res. 1992, 92:259-266.
29. Northam E.A., Anderson P.J., Werther G.A., Warne G.L., Andrewes D. Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care 1999, 22:1438-1444.
30. Northam E.A., Anderson P.J., Jacobs R., Hughes M., Warne G.L., Werther G.A. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001, 24:1541-1546.
31. Papagapiou M.P., Auer R.N. Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage. J. Cereb. Blood Flow Metab. 1990, 10:270-276.
32. Puente E.C., Silverstein J., Bree A.J., Musikantow D.R., Wozniak D.F., Maloney S., Daphna-Iken D., Fisher S.J. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes 2010, 59:1055-1062.
33. Rabie T, Marti H.H. Brain protection by erythropoietin: a manifold task. Physiology (Bethesda) 2008, 23:263-274.
34. Rao V.L., Dogan A., Todd K.G., Bowen K.K., Dempsey R.J. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats. Brain Res. 2001, 911:96-100.
35. Rovet J.F., Ehrlich R.M. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a 7-year prospective study. J. Pediatr. 1999, 134:503-506.
36. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA 1998, 95:4635-4640.
37. Schoenle E.J., Schoenle D., Molinari L., Largo R.H. Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex,. Diabetologia 2002, 45:108-114.
38. Srivastava A., Shivanandappa T. Hexachlorocyclohexane differentially alters the antioxidant status of the brain regions in rat. Toxicology 2005, 214:123-130.
39. Strudwick S.K, Carne C., Gardiner J., Foster J.K., Davis E.A., Jones T.W. Cognitive functioning in children with early onset type 1 diabetes and severe hypoglycemia,. J. Pediatr. 2005, 147:680-685.
40. Suh S.W., Aoyama K., Chen Y., Garnier P., Matsumori Y., Gum E., Liu J., Swanson R.A. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J. Neurosci. 2003, 23:10681-10690.
41. Suh S.W., Fan Y., Hong S.M., Liu Z., Matsumori Y., Weinstein P.R., Swanson R.A., Liu J. Hypoglycemia induces transient neurogenesis and subsequent progenitor cell loss in the rat hippocampus. Diabetes 2005, 54:500-509.
42. Suh S.W., Gum E.T., Hamby A.M., Chan P.H., Swanson R.A. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J. Clin. Invest 2007, 117:910-918.
43. Suh S.W., Hamby A.M., Swanson R.A. Hypoglycemia, brain energetics, and hypoglycemic neuronal death,. Glia 2007, 55:1280-1286.
44. Taoufik E, Probert L. Ischemic neuronal damage. Curr. Pharm. Des. 2008, 14:3565-3573.
45. Verdonck O, Lahrech H., Francony G., Carle O., Farion R., Van de L.Y., Remy C., Segebarth C., Payen J.F. Erythropoietin protects from post-traumatic edema in the rat brain. J. Cereb. Blood Flow Metab. 2007, 27:1369-1376.
46. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami A., Coleman T.R., Brines M., Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 2003, 198:971-975.
47. Volbracht C., van Beek J., Zhu C., Blomgren K., Leist M. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. Eur. J. Neurosci. 2006, 23:2611-2622.
48. Wakida K., Shimazawa M., Hozumi I., Satoh M., Nagase H., Inuzuka T., Hara H. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia. Neuroscience 2007, 148:105-114.
49. Wen T.C., Sadamoto Y., Tanaka J., Zhu P.X., Nakata K., Ma Y.J., Hata R., Sakanaka M. Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J. Neurosci. Res. 2002, 67:795-803.
50. Whitmer R.A., Karter A.J., Yaffe K., Quesenberry C.P., Selby J.V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301:1565-1572.
51. Wieloch T., Engelsen B., Westerberg E., Auer R. Lesions of the glutamatergic cortico-striatal projections in the rat ameliorate hypoglycemic brain damage in the striatum. Neurosci. Lett. 1985, 58:25-30.
52. Wysocki T., Harris M.A., Mauras N., Fox L., Taylor A., Jackson S.C., White N.H. Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months. Diabetes Care 2003, 26:1100-1105.
53. Xiong Y., Lu D., Qu C., Goussev A., Schallert T., Mahmood A., Chopp M. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J. Neurosurg. 2008, 109:510-521.
54. Xu L., Sapolsky R.M., Giffard R.G. Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp. Neurol. 2001, 169:416-424.
55. Yatsiv I., Grigoriadis N., Simeonidou C., Stahel P.F., Schmidt O.I., Alexandrovitch A.G., Tsenter J., Shohami E. Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury,. FASEB J. 2005, 19:1701-1703.